Skip to content

Charles River Laboratories CRL Deferred Tax Assets

Deferred Tax Assets at other companies

Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
IQVIA logo
IQVIAIQV
TEC
Bio-TechneTECH
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Plexus logo
PlexusPLXS

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's deferred tax assets?
Charles River Laboratories (CRL) reported deferred tax assets of $88.6M in Q1 2026.
How has Charles River Laboratories's deferred tax assets changed year-over-year?
Charles River Laboratories's deferred tax assets increased by 81.6% year-over-year, from $48.79M to $88.6M.
What is the long-term trend for Charles River Laboratories's deferred tax assets?
Over 5 years (2020 to 2025), Charles River Laboratories's deferred tax assets has grown at a 12.3% compound annual growth rate (CAGR), from $37.73M to $67.33M.